{
  "id": "cluster_4_doc5",
  "content": "Policy update AJM-5543: Autoimmune disorder treatment guidelines revised September 2023. Clarkston Valley region now requires failure of 2 traditional DMARDs before biologic approval. Exception process added for patients with concurrent neurodegenerative conditions. Implementation memo circulated to all network providers.",
  "metadata": {
    "format": "policy_document"
  }
}